## **Core Concept**
Non-selective beta blockers are contraindicated in diabetes due to their effect on glucose metabolism and the body's response to hypoglycemia. Beta blockers can mask symptoms of hypoglycemia and affect glucose levels.

## **Why the Correct Answer is Right**
Non-selective beta blockers, such as propranolol, block both β1 and β2 adrenergic receptors. β2 receptors play a role in glycogenolysis and gluconeogenesis in the liver and in lipolysis in adipose tissue. By blocking β2 receptors, non-selective beta blockers can inhibit the body's ability to increase glucose levels in response to hypoglycemia. Furthermore, they mask the typical sympathetic symptoms of hypoglycemia such as tremors, palpitations, and anxiety, making it difficult for patients to recognize hypoglycemic episodes.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is not provided, but typically, incorrect options might mention reasons unrelated to glucose metabolism or the response to hypoglycemia.
- **Option B:** Similarly, without the content, we assume it does not accurately describe the mechanism by which non-selective beta blockers are contraindicated in diabetes.
- **Option C:** Again, without specifics, we infer that it does not correctly relate to the effects on β2 receptors and glucose metabolism.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **selective β1 blockers** (e.g., metoprolol) are safer in diabetic patients because they have less effect on β2 receptors, which are involved in glucose metabolism. However, even with selective β1 blockers, it's crucial to monitor blood glucose levels closely.

## **Correct Answer: D.**